Literature DB >> 32906143

The coding capacity of SARS-CoV-2.

Yaara Finkel1, Orel Mizrahi1, Aharon Nachshon1, Shira Weingarten-Gabbay2,3, David Morgenstern4, Yfat Yahalom-Ronen5, Hadas Tamir5, Hagit Achdout5, Dana Stein6, Ofir Israeli6, Adi Beth-Din6, Sharon Melamed5, Shay Weiss5, Tomer Israely5, Nir Paran5, Michal Schwartz1, Noam Stern-Ginossar7.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic1. To understand the pathogenicity and antigenic potential of SARS-CoV-2 and to develop therapeutic tools, it is essential to profile the full repertoire of its expressed proteins. The current map of SARS-CoV-2 coding capacity is based on computational predictions and relies on homology with other coronaviruses. As the protein complement varies among coronaviruses, especially in regard to the variety of accessory proteins, it is crucial to characterize the specific range of SARS-CoV-2 proteins in an unbiased and open-ended manner. Here, using a suite of ribosome-profiling techniques2-4, we present a high-resolution map of coding regions in the SARS-CoV-2 genome, which enables us to accurately quantify the expression of canonical viral open reading frames (ORFs) and to identify 23 unannotated viral ORFs. These ORFs include upstream ORFs that are likely to have a regulatory role, several in-frame internal ORFs within existing ORFs, resulting in N-terminally truncated products, as well as internal out-of-frame ORFs, which generate novel polypeptides. We further show that viral mRNAs are not translated more efficiently than host mRNAs; instead, virus translation dominates host translation because of the high levels of viral transcripts. Our work provides a resource that will form the basis of future functional studies.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32906143     DOI: 10.1038/s41586-020-2739-1

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  159 in total

1.  Evolution and Epidemiology of SARS-CoV-2 Virus.

Authors:  Yu-Nong Gong; Kuo-Ming Lee; Shin-Ru Shih
Journal:  Methods Mol Biol       Date:  2022

2.  Corona Detective: a simple, scalable, and robust SARS-CoV-2 detection method based on reverse transcription loop-mediated isothermal amplification.

Authors:  Guy Aidelberg; Rachel Aronoff; Tatiana Eliseeva; Francisco Javier Quero; Hortense Vielfaure; Martin Codyre; Kathrin Hadasch; Ariel B Lindner
Journal:  J Biomol Tech       Date:  2021-09

3.  What are protective antibody responses to pandemic SARS-CoV-2?

Authors:  Jeffrey P Henderson
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 4.  Unconventional viral gene expression mechanisms as therapeutic targets.

Authors:  Jessica Sook Yuin Ho; Zeyu Zhu; Ivan Marazzi
Journal:  Nature       Date:  2021-05-19       Impact factor: 49.962

5.  SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes.

Authors:  Irwin Jungreis; Rachel Sealfon; Manolis Kellis
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

6.  Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome.

Authors:  Pramod R Bhatt; Alain Scaiola; Gary Loughran; Marc Leibundgut; Annika Kratzel; Romane Meurs; René Dreos; Kate M O'Connor; Angus McMillan; Jeffrey W Bode; Volker Thiel; David Gatfield; John F Atkins; Nenad Ban
Journal:  Science       Date:  2021-05-13       Impact factor: 63.714

7.  The Role of Fever Clinics in the Strategic Triage of Suspected Cases of Imported COVID-19.

Authors:  Hui Jia; Yuele Chang; Long Zhao; Yunxia Li; Lei Chen; Qian Zhang; Xianzhi Lou; Chenwei Li; Shuyue Xia
Journal:  Int J Gen Med       Date:  2021-05-25

Review 8.  I(nsp1)ecting SARS-CoV-2-ribosome interactions.

Authors:  Matthieu Simeoni; Théo Cavinato; Daniel Rodriguez; David Gatfield
Journal:  Commun Biol       Date:  2021-06-10

9.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Authors:  Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Kathleen M E Gallagher; Matthew R Bauer; Hannah B Taylor; W Augustine Dunn; Christina Tarr; John Sidney; Suzanna Rachimi; Hasahn L Conway; Katelin Katsis; Yuntong Wang; Del Leistritz-Edwards; Melissa R Durkin; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Isabel P Carulli; Vipheaviny A Chea; Abishek Chandrashekar; Cansu Cimen Bozkus; Mary Carrington; Nina Bhardwaj; Dan H Barouch; Alessandro Sette; Marcela V Maus; Charles M Rice; Karl R Clauser; Derin B Keskin; Daniel C Pregibon; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti
Journal:  Cell       Date:  2021-06-03       Impact factor: 66.850

Review 10.  SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.

Authors:  Natalia Redondo; Sara Zaldívar-López; Juan J Garrido; Maria Montoya
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.